Psychiatric and medical effects of anabolic-androgenic steroid use in women

Psychotherapy and Psychosomatics

Volumn 69, Issue 1, 2000, Pages 19-26

  Gruber, Amanda J ^a   Pope Jr , Harrison G ^b  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

Anabolic androgenic steroids; Body dysmorphic disorder; Eating disorders; Ergogenic substance abuse; Gender identity disorder; Substance abuse; Women

Indexed keywords

ANABOLIC AGENT; ANDROGEN; BOLDENONE; ILLICIT DRUG; MESTEROLONE; METANDIENONE; METENOLONE; NANDROLONE; OXANDROLONE; OXYMETHOLONE; STANOZOLOL; TESTOSTERONE DERIVATIVE;

ADULT; ARTICLE; ATHLETE; BODY DYSMORPHIC DISORDER; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; EATING DISORDER; FEMALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MORBIDITY; MUSCLE DEVELOPMENT; PHYSICAL PERFORMANCE; PHYSIOLOGY; PSYCHIATRY; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANABOLIC AGENTS; EATING DISORDERS; FEMALE; GENDER IDENTITY; HUMANS; MENTAL DISORDERS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SPORTS; SUBSTANCE-RELATED DISORDERS; TESTOSTERONE CONGENERS;

EID: 0033991904     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012362     Document Type: Article

References (30)

1. Forbes GB, Porta CR, Herr BE, Griggs RC: Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. JAMA 1992;267:397-399.
2. Bagatell CJ, Heiman JR, Matsumoto AM, Rivier JE, Bremner WJ: Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. J Clin Endocrinol Metab 1994; 79:561-567.
3. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R: The effect of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996; 335:1-7.
4. Pope HG Jr, Katz DL: Psychiatric and medical effects of anabolic-androgenic steroid use. Arch Gen Psychiatry 1994;51:375-382.
5. Brower KJ, Blow FC, Young JP, Hill EM: Symptoms and correlates of anabolic-androgenic steroid dependence. Br J Addict 1991;86: 759-768.
6. Rubinow DR, Schmidt PJ: Androgens, brain, and behavior. Am J Psychiatry 1996;153:974-984.
7. Pope HG Jr, Katz DL: Psychiatric effects of exogenous anabolic-androgenic steroids; in Wolkowitz OM, Rothschild AJ (eds): Psychoneuroendocrinology for the clinician. Washington, American Psychiatric Press, in press.
8. Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS: Anabolic-androgenic steroid use in the United States. JAMA 1993;270:1217-1221.
9. Johnson MD, Jay MS, Shoup B, Rickert VI: Anabolic steroid use in adolescent males. Pediatrics 1989;83:921-924.
10. Johnston L, Bachman J, O'Malley P: Monitoring the Future: Continuing Study of the Lifestyles and Values of Youth. Ann Arbor, University of Michigan Institute for Social Research, 1990-1991.
11. Ross J, Winters F, Hartmann K, et al: 1988-89 Survey of Substance Abuse among Maryland adolescents. Baltimore, Maryland Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration, 1989.
12. DuRant RH, Rickert VI, Ashworth CS, Newman C, Stevens G: Use of multiple drugs among adolescents who abuse anabolic steroids. N Engl J Med 1993;328:922-926.
13. Terney R, McLain L: The use of anabolic steroids in high school students. Am J Dis Child 1990;144:99-103.
14. Radokovich J, Broderick P, Pickell G: Rates of anabolic-androgenic steroid abuse among students in junior high school J Am Board Fam Pract 1993;6:341-345.
15. Yesalis LE, Barsukiewicz CK, Kopstein AN, Bahrke MS: Trends in anabolic-androgenic steroid use among adolescents. Arch Pediatr Adolesc Med 1997;151:1197-1206.
16. Strauss R, Liggett M, Lanese R: Anabolic steroid use and perceived effects in ten weight-trimmed women athletes. JAMA 1985;253: 2871-2873.
17. Moffa HR, Wallace M, Sady S: Effects of anabolic steroids on lipoprotein profiles of female weight lifters. Physician Sportsmed 1990;18: 106-110.
18. Malarkey WB, Strauss RH, Leizman DJ, Liggett M, Demers LM: Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids. Am J Obstet Gynecol 1991;165:1385-1390.
19. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). New York, New York State Psychiatric Institute, 1989.
20. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3 (DSM-IV). Washington, American Psychiatric Association, 1987.
21. Pope HG Jr, Gruber AJ, Choi PY, Olivardia R, Phillips KA: Muscle dysmorphia: An underrecognized form of body dysmorphic disorder. Psychosomatics 1997;38:548-557.
22. Jackson AS, Pollock ML, Ward A: Generalized equations for predicting body density of women. Med Sci Sports Exerc 1980;12:175-182.
23. Kouri EM, Pope HG Jr, Katz DL, Oliva PS: Fat-free mass index in users and non-users of anabolic-androgenic steroids. Clin J Sport Med 1995;5:223-228.
24. Bjorntorp P: The android woman - A risky condition. J Intern Med 1996;239:105-110.
25. Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995;63:1-8.
26. Gruber AJ, Pope HG Jr: Ephedrine abuse among 36 female weightlifters. Am J Addict 1998;7:256-261.
27. Wines JD Jr, Gruber AJ, Pope HG Jr, Lukas SE: Nalbuphine hydrochloride dependence in anabolic steroid users. Am J Addict, in press.
28. Pope HG Jr, Kouri EM, Hudson JI: The effects of supraphysiologic doses of testosterone on mood and aggression in men. Arch Gen Psychiatry, in press.
29. Patten SB, Love EJ: Drug-induced depression. Psychother Psychosom 1997;66:63-73.
30. Ling MHM, Perry PJ, Tsuang MT: Side effects of corticosteroid therapy: Psychiatric aspects. Arch Gen Psychiatry 1981;38:471-477.